BIOCON HAS GIVEN A BREAKOUT WITH VOLUMES WHICH SHOWS PROFESSIONAL MONEY IS INVOLVED THE STOCK HAS HIT A LIFETIME HIGH A LOW VOLUME TEST OF THE SUPPORT WOULD BE THE NEXT SIGNAL TO ADD TO EXISTING POSITIONS. STOPLOSS - 320 TARGET - AS LONG AS TRENDING.